DoD Arthritis Research, Clinical Research Award
ID: 356099Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/356099
Timeline
    Description

    The Department of the Army, through the US Army Medical Research and Materiel Command (USAMRAA), is offering the FY24 Arthritis Clinical Research Award (ATRP CRA) to support innovative clinical research aimed at improving outcomes for individuals affected by various types of arthritis. This grant program encourages proposals that address disease-specific factors and interventions, with a focus on military relevance and the potential for significant clinical impact, particularly for Service Members, Veterans, and their families. With an estimated total program funding of $6 million, the program anticipates awarding approximately three grants, including one for a clinical trial option, with applications due by October 30, 2024. Interested applicants can reach out to the CDMRP Help Desk at help@eBRAP.org for further assistance.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT9425FY24ATRPCRA_GG.pdf
    The Department of Defense's FY24 Arthritis Clinical Research Award aims to fund innovative, high-impact research focused on mitigating the effects of arthritis on service members and the general population. With a total budget of $10 million, the program encourages applications that address specific focus areas, including prevention, diagnosis, and intervention strategies for various types of arthritis. Eligible applicants can include academic institutions, non-profit organizations, and military personnel, with a pre-application deadline of October 16, 2024, and a full application deadline of October 30, 2024. Research proposals should demonstrate military relevance, potential clinical impact, and an intention to transition findings into practical applications. The award supports clinical trials with a maximum budget of up to $3 million and requires preliminary data. Applications must include detailed research strategies, recruitment plans, and a clear path to implementing findings post-award. The selection process involves peer review based on scientific merit and programmatic relevance, ultimately aimed at enhancing arthritis care and improving health outcomes for affected individuals.
    Similar Opportunities
    Staff Research Program
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity for the Staff Research Program, aimed at engaging scientific staff in collaborative research with higher education institutions. This program seeks to enhance the professional competence of Army Research Office (ARO) scientists through hands-on, fundamental research in various scientific fields, including engineering, physical sciences, and life sciences, with a focus on advancing knowledge relevant to Army missions. Eligible applicants include institutions recognized for their scientific research capabilities, and the funding will be provided through cooperative agreements with award amounts ranging from $200,000 to $10 million. Proposals must be submitted via Grants.gov by June 2, 2030, and interested parties can contact Mr. William Creech at William.a.creech3.civ@army.mil for further information.
    Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering Exploratory Clinical Trial Grants (R61) to support research in arthritis and musculoskeletal and skin diseases. This funding opportunity aims to facilitate short-term, interventional studies that address critical research questions, particularly those evaluating drug efficacy in rare diseases, without requiring preliminary data. Grants can provide up to $600,000 over three years, with applications due by November 2, 2026. Interested applicants are encouraged to consult with NIH staff during the application process and can find additional information at NIH Grants or by contacting NIH Grants Information at grantsinfo@nih.gov.
    Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding opportunities through the "Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases" program, specifically under the R61 Clinical Trial mechanism. This initiative aims to support short-term exploratory clinical trials that investigate treatments for rheumatic, musculoskeletal, and skin conditions, with a focus on diverse therapeutic approaches. Eligible applicants include a wide range of organizations such as higher education institutions, nonprofits, and state and local governments, with a maximum budget of $600,000 for a three-year project, not exceeding $300,000 in any single year. Applications must be submitted electronically via Grants.gov, with key deadlines starting from February 4, 2024, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov. For more details, visit the official announcement at https://grants.nih.gov/grants/guide/pa-files/PAR-24-035.html.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has announced a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development. This opportunity invites unrestricted applicants to submit proposals aimed at advancing biomedical research and development, with a focus on enhancing human performance. The program is critical for fostering innovation in science and technology, particularly in areas that support the Department of Defense's mission. The estimated total program funding is $10 million, with individual awards ranging from $750,000 to $50 million, and proposals are due by July 31, 2028. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    Tactical Behaviors for Autonomous Maneuver
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity through the Tactical Behaviors for Autonomous Maneuver Collaborative Research Program (TBAM-CRP) aimed at enhancing the capabilities of robotic and autonomous systems (RAS) for military operations in complex environments. This program seeks proposals that develop coordinated and adaptive behaviors for small groups of autonomous agents, focusing on innovative maneuver tactics and strategies to operate effectively in multi-domain operations against peer adversaries. The TBAM-CRP is critical for advancing military capabilities, leveraging new technologies in robotics and autonomous systems to improve situational awareness and operational effectiveness on the battlefield. Interested applicants, including institutions of higher education and for-profit organizations, are invited to submit proposals by April 24, 2024, with funding amounts ranging from $100,000 to $2.3 million available per award. For further inquiries, applicants can contact Christopher D. Justice at usarmy.adelphi.devcom-arl.mbx.tbam-crp-questions@army.mil.
    NFRP Outreach and Invitation for Response
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is forecasting an opportunity for a Research-based Other Transactions Agreement (rOTA) under the Neurofibromatosis Research Program (NFRP). This initiative aims to accelerate the clinical translation of basic research related to neurofibromatosis (NF) by conducting collaborative Phase I and II clinical trials focused on promising therapeutic agents for NF1, NF2, and schwannomatosis. Historically, this requirement has been addressed through assistance agreements, and the government is now seeking feedback on this proposed approach, emphasizing the need for cost-sharing arrangements and access to patient populations. Interested parties can direct inquiries to Jason D. Kuhns at jason.d.kuhns.civ@mail.mil, with the opportunity being part of the FY21 portfolio and requiring a demonstrated history of collaborative research among participants.
    Advanced Rehabilitation Research Training (ARRT) Program - Health and Function
    Administration for Community Living
    The Administration for Community Living is offering a grant opportunity through the Advanced Rehabilitation Research Training (ARRT) Program, aimed at enhancing health and function outcomes for individuals with disabilities. This program seeks to provide advanced research training and experience to individuals holding doctorates or similar advanced degrees, with a focus on multidisciplinary disability and rehabilitation research. The grant, which has a funding ceiling of $250,000 and a floor of $245,000, is intended for private and public institutions of higher education, with one award expected to be made for a project period of 36 months. Interested applicants can reach out to Courtney Ward-Sutton at (202) 240-3164 or via email at Courtney.Ward-Sutton@acl.hhs.gov for further details, and must submit their proposals by December 5, 2025.
    Advanced Rehabilitation Research Training (ARRT) Program - Community Living and Participation
    Administration for Community Living
    The Administration for Community Living is offering a grant opportunity through the Advanced Rehabilitation Research Training (ARRT) Program, aimed at enhancing community living and participation outcomes for individuals with disabilities. This program seeks to provide advanced research training to individuals holding doctorates or similar advanced degrees, focusing on multidisciplinary disability and rehabilitation research. The grant, with a funding ceiling of $250,000 and a floor of $245,000, will support one project over a 36-month period, with applications due by December 5, 2025. Interested applicants can reach out to Courtney Ward-Sutton at (202) 240-3164 or via email at Courtney.Ward-Sutton@acl.hhs.gov for further information.
    NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), is offering a funding opportunity for the implementation of interventional clinical trials via the Clinical Trial Implementation Cooperative Agreement (UG3/UH3). This initiative aims to support investigation-driven projects for both single and multi-site trials across all phases, emphasizing the importance of preliminary planning and the completion of necessary approvals before trial execution. The funding opportunity reflects NIAMS' commitment to advancing research in arthritis and musculoskeletal diseases, with grants of up to $250,000 available for the UG3 phase and no specific limit for UH3 project budgets, designed for up to six years of support. Interested applicants can find more information and application details at the provided link, with the application deadline set for March 4, 2027.
    Advanced Rehabilitation Research Training (ARRT) Program - Employment
    Administration for Community Living
    The Administration for Community Living is offering a grant opportunity through the Advanced Rehabilitation Research Training (ARRT) Program focused on employment outcomes for individuals with disabilities. This program aims to provide advanced research training and experience to individuals holding doctorates or similar advanced degrees, specifically targeting the enhancement of multidisciplinary disability and rehabilitation research. The grant, with a funding ceiling of $250,000 and a floor of $245,000, will support one project over a 36-month period, with applications due by December 5, 2025. Interested applicants can reach out to Courtney Ward-Sutton at (202) 240-3164 or via email at Courtney.Ward-Sutton@acl.hhs.gov for further information.